Busulfan
Showing 676 - 700 of 765
Acute Myeloid Leukemia Trial in Seoul (Fludarabine, Busulfan, Thymoglobulin)
Unknown status
- Acute Myeloid Leukemia
- Fludarabine, Busulfan, Thymoglobulin
-
Seoul, Chongno-gu, Korea, Republic ofSeoul National University Hospital
Mar 23, 2012
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Portland (biological, drug, procedure, radiation)
Terminated
- Chronic Myeloproliferative Disorders
- +7 more
- filgrastim
- +7 more
-
Portland, OregonOHSU Knight Cancer Institute
May 24, 2012
Multiple Myeloma, Lymphoma Trial in Houston (Busulfan, Melphalan)
Completed
- Multiple Myeloma
- Lymphoma
- Busulfan
- Melphalan
-
Houston, TexasUT MD Anderson Cancer Center
Dec 15, 2011
GVHD, Leukemia, Lymphoma Trial in Cleveland (biological, drug, procedure, radiation)
Completed
- Graft Versus Host Disease
- +4 more
- anti-thymocyte globulin
- +6 more
-
Cleveland, OhioCase Medical Center, University Hospitals Seidman Cancer Center,
Mar 14, 2012
Multiple Myeloma and Plasma Cell Tumor Trial in Seattle (biological, drug, procedure, radiation)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- recombinant interferon alfa
- +4 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Nov 15, 2011
Chronic Myelogenous Leukemia Trial in Houston (Busulfan, Cyclophosphamide, Imatinib Mesylate)
Completed
- Chronic Myelogenous Leukemia
- Busulfan
- +3 more
-
Houston, TexasUT MD Anderson Cancer Center
Oct 31, 2011
Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myeloid, Chronic Trial in Tehran (Stem cell Transplantation)
Unknown status
- Leukemia, Myeloid, Acute
- +2 more
- Stem cell Transplantation
-
Tehran, Iran, Islamic Republic ofHematology-Oncology & SCT Research Center
May 31, 2012
Mucopolysaccharidosis Trial in Teharn (Conditioning regimen, Graft-versus-host disease (GVHD) prophylaxis, Stem Cell
Unknown status
- Mucopolysaccharidosis
- Conditioning regimen
- +2 more
-
Teharn, Tehran, Iran, Islamic Republic ofHematology-Oncology & SCT Research Center
May 31, 2012
Leukemia Trial in Houston (Autologous Dendritic Cells)
Terminated
- Leukemia
- Autologous Dendritic Cells
-
Houston, TexasUT MD Anderson Cancer Center
Jul 27, 2012
Multiple Myeloma and Plasma Cell Tumor Trial in Seattle (busulfan, melphalan, thiotepa)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- busulfan
- +4 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Jun 21, 2011
Aplastic Anemia Trial in Seoul (Cyclophosphosphamide, TBI)
Unknown status
- Aplastic Anemia
- Cyclophosphosphamide, TBI
-
Seoul, Korea, Republic ofSeoul National University Hospital
Mar 23, 2012
Multiple Myeloma and Plasma Cell Tumor Trial in Marseille (biological, drug, procedure)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- anti-thymocyte globulin
- +4 more
-
Marseille, FranceMarseille Institute of Cancer - Institut J. Paoli and I. Calmett
May 13, 2011
Acute Leukemias, Chronic Leukemias, Myelodysplastic Syndrome Trial (Busulfan/Cyclophosphamide)
Unknown status
- Acute Leukemias
- +3 more
- (no location specified)
Apr 20, 2011
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Marseille (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- therapeutic immune globulin
- +3 more
-
Marseille, FranceMarseille Institute of Cancer - Institut J. Paoli and I. Calmett
May 14, 2011
Mucositis, Hematopoietic Stem Cell Transplantation Trial in Tehran (Oral selenium, Oral )
Unknown status
- Mucositis
- Hematopoietic Stem Cell Transplantation
- Oral selenium
- Oral placebo
-
Tehran, Iran, Islamic Republic ofHematology-Oncology & SCT Research Center
May 31, 2012
Leukemia Trial in Marseille (amsacrine, busulfan, cytarabine)
Completed
- Leukemia
- amsacrine
- +8 more
-
Marseille, FranceMarseille Institute of Cancer - Institut J. Paoli and I. Calmett
May 12, 2011
Leukemia, Myelodysplastic Syndrome Trial in Seoul (BuCy vs BuFlu)
Completed
- Leukemia
- Myelodysplastic Syndrome
- BuCy vs BuFlu
-
Seoul, Korea, Republic ofAsan Medical Center
Feb 10, 2011
Chronic Myeloid Leukemia Trial in New York (Reduced Intensity Conditioning, Busulfan and Fludarabine)
Terminated
- Chronic Myeloid Leukemia
- Reduced Intensity Conditioning, Busulfan and Fludarabine
-
New York, New YorkMorgan Stanley Children's Hospital of NYP
Apr 12, 2011
Acute Myeloid Leukemia Trial in Memphis (drug, procedure, radiation)
Completed
- Acute Myeloid Leukemia
- Fludarabine, Cytarabine, Liposomal daunorubicin (DaunoXome)
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 5, 2011
Bone Marrow Failure, Osteopetrosis, Fanconi Anemia Trial in New York (Fludarabine, Cyclophosphamide, Cyclophosphamide 40)
Unknown status
- Bone Marrow Failure
- +3 more
- Fludarabine
- +3 more
-
New York, New YorkColumbia University Medical Center
Oct 18, 2011
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Jerusalem (Campath-1H /ATG)
Withdrawn
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Campath-1H /ATG
-
Jerusalem, IsraelHadassah Medical Organization
Apr 7, 2011
GVHD Trial in Freiburg (ATG-Fresenius S)
Completed
- Graft vs Host Disease
- ATG-Fresenius S
-
Freiburg, Baden-Württemberg, GermanyUniversität Freiburg, Medizinische Klinik, Abteilung Innere Medi
Dec 9, 2011
Solid Tumors, Hematologic Tumors Trial in Clermont-Ferrand (Fludarabine, Busulfan, Thymoglobulin)
Unknown status
- Solid Tumors
- Hematologic Neoplasms
- Fludarabine, Busulfan, Thymoglobulin
-
Clermont-Ferrand, FrancePaillard Catherine
Jan 18, 2011
Neuroblastoma Trial in Clermont-Ferrand (Busulfan - Fludarabine - TBI)
Unknown status
- Neuroblastoma
- Busulfan - Fludarabine - TBI
-
Clermont-Ferrand, FranceCHU Clermont-Ferrand
Jan 18, 2011